Labeler · US market

Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals Inc is a US drug labeler with US FDA registrations covering 1 drug concept (1 currently active) across 1 packages. It is currently the only active US supplier of 1 drug.

ACTIVE — US

openFDA · updated weekly

Labeler codes69516

Active drugs1

Registrations1 active / 1

Packages1

Sole supplier of1 drugs

Portfolio1 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Linerixibat tablet, film coated	rx	1	1	SUPPLYING

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Linerixibatrx

At a glance

TypeLabeler
Labeler codes69516
Filing names1
Drugs (active)1
Drugs (all time)1
US registrations1
Packages1

Recent events

Shortages, recalls, and registration changes across all filing names.

Sep 19, 2025
RESOLVEDShortage resolved: Obeticholic Acid Tablet (Intercept Pharmaceuticals)
Sep 19, 2025
SHORTAGEDrug shortage: Obeticholic Acid Tablet (Intercept Pharmaceuticals)

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.